No. | Drug Name | Active Ingredient | Date | What It’s Used For |
23. | Orbactiv | oritavancin | 8/6/2014 | To treat adults with skin infections$ L& r! G- q7 U% ^
Press Release |
22. | | empagliflozin | 8/1/2104 | To improve gylcemic control in adults with type 2 diabetes* j L& ^5 ?4 C1 w
Press Release |
21. | | olodaterol | 7/31/2014 | To treat chronic obstructive pulmonary disease
: _8 K. \3 D% u! C0 f, x3 \ Press Release |
20.
! i1 I+ }) W, P0 W0 s. ^9 s2 Z/ c 3 u. h5 Z8 O* C% l
| | idelalisib | 7/23/2014 | To treat patients with trhee types of blood cancers
* W( c2 H8 ]3 {$ R8 x2 Z+ O Press Release |
19. | Kerydin, E( B: U" b2 O0 M t2 y; s: G
a" k! W; C/ }+ p, L+ f7 }! v | tavaborole | 7/7/2014 | For the topical treatment of onychomycosis of the toenails % }. G4 I" c+ ]/ [
(No Press Release) |
18. | | belinostat | 7/3/2014 | To treat patients with peripheral T-cell lymphoma (PTCL) 8 k, S& @9 B, J$ k; Q. A& c8 m
Press Release |
17. | | tedizolid phosphate | 6/20/2014 | To treat adults with skin infections0 k) Z/ J$ y; B+ M1 v. @
Press Release |
16. | Jublia( @ P, \$ m; d! Q C3 I) ?
$ `6 Y3 |" }. Q: E* o
| efinaconazole | 6/6/2014 | Treat mild to moderate onychomycosis (fungal infection)
$ \' E$ F: ~7 f. k2 q9 G$ f: | No Press Release |
15. | Dalvance
; k. A5 w9 h+ g9 H
4 `/ o& f2 I! U* |8 h) J+ z | dalbavancin | 5/23/2014 | To treat adults with skin infections
6 Z! I: }: ~, C Press Release |
14. | Entyvio
: W7 o5 w' g0 v: @) |4 j5 r: n ! d( X% o" P* ~6 Z/ Y
| vedolizumab | 5/20/2014 | To treat adult patients with moderate to severe ulcerative colitis and adult patients with moderate to severe Crohn‘s disease
3 k, @, W( b& ^0 s) l5 Q/ U& A Press Release |
13. | | vorapaxar | 5/8/2014 | To reduce the risk of heart attacks and stroke in high-risk patients- I/ Z8 w. S' i) p7 p4 ? O) z
Press Release |
12. | | ceritinib | 4/29/2014 | To treat patients with a certain type of late-stage (metastatic) non-small cell lung cancer (NSCLC)1 h% e/ i) m X6 U
Press Release |
11. | | siltuximab | 4/23/2014 | To treat patients with multicentric Castleman’s disease (MCD), a rare disorder similar to lymphoma (cancer of the lymph nodes)* s& o4 m* g0 }7 A* J
Press Release |
10. | | ramucirumab | 4/21/2014 | To treat patients with advanced stomach cancer or gastroesophageal junction adenocarcinoma! y. K5 K2 M* e+ i; |
Press Release |
9. | | albiglutide | 4/15/2014 | To improve glycemic control, along with diet and exercise, in adults with type 2 diabetes
. S9 a8 n" ]9 G$ v( @" | Press Release |
8. | | apremilast | 3/21/2014 | To treat adults with active psoriatic arthritis (PsA)
5 Z* [. z/ F4 a4 y Press Release |
7. | | miltefosine | 3/19/2014 | To treat a tropical disease called leishmaniasis$ e/ b3 ~6 \! I9 D+ h; [( g
Press Release |
6. | | florbetaben F 18 injection | 3/19/2014 | For Positron EmissionTomography (PET) imaging of the brain |
5. | | metreleptin for injection | 2/24/2014 | To treat the complications of leptin deficiency+ j R* M3 A1 a
Press Release |
4. | | droxidopa | 2/18/2014 | To treat neurogenic orthostatic hypotension (NOH)
2 \9 }2 _* n7 j f$ j Press Release |
3. | | elosulfase alfa | 2/14/2014 | Treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome)
; G' y3 W, B" G& t$ } Press Release |
2. | | tasimelteon | 1/31/2014 | To treat non-24- hour sleep-wake disorder (“non-24”) in totally blind individuals. Non-24 is a chronic circadian rhythm (body clock) disorder in the blind that causes problems with the timing of sleep.Press Release |
1. | | dapaglifozin | 1/8/2014 | To improve glycemic control, along with diet and exercise, in adults with type 2 diabetes
9 w, f0 T- S# o7 u: T Press Release |